(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine

C85H112Cl2N16O7 — CID 159366937

IUPAC(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine
SMILESCN1CCC(CCN)CC1.CN1CCC(CCNC(=O)/C=C/c2ccc(-c3cc(Cl)c4cnccc4n3)o2)CC1.CN1CCC(CCNC(=O)/C=C/c2ccc(-c3cc(NCCCN4CCCCC4)c4cnccc4n3)o2)CC1.NCCCN1CCCCC1.O=C(O)/C=C/c1ccc(-c2cc(Cl)c3cnccc3n2)o1
InChIInChI=1S/C31H42N6O2.C23H25ClN4O2.C15H9ClN2O3.2C8H18N2/c1-36-20-12-24(13-21-36)10-16-34-31(38)9-7-25-6-8-30(39-25)29-22-28(26-23-32-15-11-27(26)35-29)33-14-5-19-37-17-3-2-4-18-37;1-28-12-8-16(9-13-28)6-11-26-23(29)5-3-17-2-4-22(30-17)21-14-19(24)18-15-25-10-7-20(18)27-21;16-11-7-13(18-12-5-6-17-8-10(11)12)14-3-1-9(21-14)2-4-15(19)20;1-10-6-3-8(2-5-9)4-7-10;9-5-4-8-10-6-2-1-3-7-10/h6-9,11,15,22-24H,2-5,10,12-14,16-21H2,1H3,(H,33,35)(H,34,38);2-5,7,10,14-16H,6,8-9,11-13H2,1H3,(H,26,29);1-8H,(H,19,20);8H,2-7,9H2,1H3;1-9H2/b9-7+;5-3+;4-2+;;
InChIKeyLJGBXDOKUIAUMB-OVKWFMSFSA-N
MW1540.84 g/mol
LogP14.58
Rot. Bonds25

About (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine

(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine (PubChem CID 159366937) has the molecular formula C85H112Cl2N16O7 and a molecular weight of 1540.84 g/mol. Its IUPAC name is (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine.

Molecular Properties

Compound Name(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine
PubChem CID159366937
Molecular FormulaC85H112Cl2N16O7
Molecular Weight1540.84 g/mol
Exact Mass1538.83
IUPAC Name(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine
SMILESCN1CCC(CCN)CC1.CN1CCC(CCNC(=O)/C=C/c2ccc(-c3cc(Cl)c4cnccc4n3)o2)CC1.CN1CCC(CCNC(=O)/C=C/c2ccc(-c3cc(NCCCN4CCCCC4)c4cnccc4n3)o2)CC1.NCCCN1CCCCC1.O=C(O)/C=C/c1ccc(-c2cc(Cl)c3cnccc3n2)o1
InChIInChI=1S/C31H42N6O2.C23H25ClN4O2.C15H9ClN2O3.2C8H18N2/c1-36-20-12-24(13-21-36)10-16-34-31(38)9-7-25-6-8-30(39-25)29-22-28(26-23-32-15-11-27(26)35-29)33-14-5-19-37-17-3-2-4-18-37;1-28-12-8-16(9-13-28)6-11-26-23(29)5-3-17-2-4-22(30-17)21-14-19(24)18-15-25-10-7-20(18)27-21;16-11-7-13(18-12-5-6-17-8-10(11)12)14-3-1-9(21-14)2-4-15(19)20;1-10-6-3-8(2-5-9)4-7-10;9-5-4-8-10-6-2-1-3-7-10/h6-9,11,15,22-24H,2-5,10,12-14,16-21H2,1H3,(H,33,35)(H,34,38);2-5,7,10,14-16H,6,8-9,11-13H2,1H3,(H,26,29);1-8H,(H,19,20);8H,2-7,9H2,1H3;1-9H2/b9-7+;5-3+;4-2+;;
InChIKeyLJGBXDOKUIAUMB-OVKWFMSFSA-N
XLogP14.58
TPSA292.53 Ų
H-Bond Donors6
H-Bond Acceptors20
Rotatable Bonds25
Heavy Atoms110
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001540.84
LogP ≤ 514.58
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine?
The IUPAC name of (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine (CID 159366937) is (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine.
What is the SMILES notation for (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine?
The canonical SMILES for (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine is CN1CCC(CCN)CC1.CN1CCC(CCNC(=O)/C=C/c2ccc(-c3cc(Cl)c4cnccc4n3)o2)CC1.CN1CCC(CCNC(=O)/C=C/c2ccc(-c3cc(NCCCN4CCCCC4)c4cnccc4n3)o2)CC1.NCCCN1CCCCC1.O=C(O)/C=C/c1ccc(-c2cc(Cl)c3cnccc3n2)o1.
What is the InChIKey of (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine?
The InChIKey is LJGBXDOKUIAUMB-OVKWFMSFSA-N. The full InChI is InChI=1S/C31H42N6O2.C23H25ClN4O2.C15H9ClN2O3.2C8H18N2/c1-36-20-12-24(13-21-36)10-16-34-31(38)9-7-25-6-8-30(39-25)29-22-28(26-23-32-15-11-27(26)35-29)33-14-5-19-37-17-3-2-4-18-37;1-28-12-8-16(9-13-28)6-11-26-23(29)5-3-17-2-4-22(30-17)21-14-19(24)18-15-25-10-7-20(18)27-21;16-11-7-13(18-12-5-6-17-8-10(11)12)14-3-1-9(21-14)2-4-15(19)20;1-10-6-3-8(2-5-9)4-7-10;9-5-4-8-10-6-2-1-3-7-10/h6-9,11,15,22-24H,2-5,10,12-14,16-21H2,1H3,(H,33,35)(H,34,38);2-5,7,10,14-16H,6,8-9,11-13H2,1H3,(H,26,29);1-8H,(H,19,20);8H,2-7,9H2,1H3;1-9H2/b9-7+;5-3+;4-2+;;.
What are the key properties of (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine?
(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine has a molecular weight of 1540.84 g/mol, XLogP of 14.58, 25 rotatable bonds, 6 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]-N-[2-(1-methylpiperidin-4-yl)ethyl]prop-2-enamide;(E)-3-[5-(4-chloro-1,6-naphthyridin-2-yl)furan-2-yl]prop-2-enoic acid;2-(1-methylpiperidin-4-yl)ethanamine;(E)-N-[2-(1-methylpiperidin-4-yl)ethyl]-3-[5-[4-(3-piperidin-1-ylpropylamino)-1,6-naphthyridin-2-yl]furan-2-yl]prop-2-enamide;3-piperidin-1-ylpropan-1-amine is sourced from PubChem (CID 159366937), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).